-
1Inequalities in enrollment of women and racial minorities in trials testing uric acid lowering drugs
المؤلفون: Antonio Di Micoli, Arrigo F G Cicero, Daniela Degli Esposti, Claudio Borghi, Federica Fogacci
المساهمون: Federica Fogacci, Claudio Borghi, Antonio Di Micoli, Daniela Degli Esposti, Arrigo F G Cicero
المصدر: Nutrition, metabolism, and cardiovascular diseases : NMCD. 31(12)
مصطلحات موضوعية: Minoritie, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Population, Medicine (miscellaneous), Hyperuricemia, Gout Suppressants, chemistry.chemical_compound, Sex Factors, Internal medicine, medicine, Rasburicase, Humans, Healthcare Disparities, education, education.field_of_study, Clinical Trials as Topic, Nutrition and Dietetics, business.industry, Lesinurad, medicine.disease, Gout, Clinical trial, Uric acid lowering drugs, Pegloticase, chemistry, Ethnic and Racial Minorities, Sex, Female, Febuxostat, Cardiology and Cardiovascular Medicine, business, medicine.drug
وصف الملف: STAMPA
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::341482393646333003314a2657f49c65Test
https://pubmed.ncbi.nlm.nih.gov/34656384Test -
2دورية أكاديمية
المصدر: Reinders , M K , van Roon , E N , Houtman , P M , Brouwers , J R B J & Jansen , T L T A 2007 , ' Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients ' , Clinical Rheumatology , vol. 26 , no. 9 , pp. 1459-1465 . https://doi.org/10.1007/s10067-006-0528-3Test
مصطلحات موضوعية: allopurinol, benzbromarone, gout, probenecid, hyperuricemia, SEVERE TOPHACEOUS GOUT, URIC-ACID, MANAGEMENT, ARTHRITIS, ATTACKS, RASBURICASE, PREVENTION, REDUCTION, THERAPY
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1007/s10067-006-0528-3Test
https://hdl.handle.net/11370/ce633fb5-ed53-400e-bda3-3c8f77cf23dfTest
https://research.rug.nl/en/publications/ce633fb5-ed53-400e-bda3-3c8f77cf23dfTest
https://pure.rug.nl/ws/files/2803994/Reinders_2007_Clin_Rheumatol.pdfTest -
3دورية أكاديمية
المؤلفون: Strilchuk L, Fogacci F, Cicero AF
المساهمون: Strilchuk L, Fogacci F, Cicero AF
مصطلحات موضوعية: Allopurinol, benzbromarone, febuxostat, gout, lesinurad, pegloticase, probenecid, rasburicase, safety
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30915866; info:eu-repo/semantics/altIdentifier/wos/WOS:000467693000002; volume:18; issue:4; firstpage:261; lastpage:271; numberofpages:11; journal:EXPERT OPINION ON DRUG SAFETY; http://hdl.handle.net/11585/722671Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85065042457
-
4
المؤلفون: Janet E. Pope, Tony Zhang
المصدر: Rheumatology. 56:1144-1153
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Gout, Urate Oxidase, Allopurinol, 030204 cardiovascular system & hematology, Pharmacology, Placebo, Gout Suppressants, Polyethylene Glycols, law.invention, 03 medical and health sciences, Benzbromarone, chemistry.chemical_compound, Febuxostat, 0302 clinical medicine, Rheumatology, Randomized controlled trial, law, Internal medicine, medicine, Rasburicase, Humans, Pharmacology (medical), Randomized Controlled Trials as Topic, 030203 arthritis & rheumatology, Arthritis, Gouty, business.industry, Middle Aged, Prognosis, medicine.disease, Treatment Outcome, chemistry, Pegloticase, Cardiovascular Diseases, Chronic Disease, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d157b32fecb1bd5f79dc82d64168578dTest
https://doi.org/10.1093/rheumatology/kex065Test -
5
المؤلفون: Larysa Strilchuk, Arrigo Fg Cicero, Federica Fogacci
المساهمون: Strilchuk L, Fogacci F, Cicero AF
مصطلحات موضوعية: safety, Xanthine Oxidase, medicine.medical_specialty, Allopurinol, 030204 cardiovascular system & hematology, Gout Suppressants, pegloticase, 03 medical and health sciences, chemistry.chemical_compound, Benzbromarone, lesinurad, 0302 clinical medicine, gout, Internal medicine, benzbromarone, medicine, Humans, Pharmacology (medical), Hyperuricemia, Enzyme Inhibitors, business.industry, febuxostat, Lesinurad, General Medicine, Uricosuric Agents, medicine.disease, Uric Acid, Gout, Topiroxostat, probenecid, chemistry, Tolerability, 030220 oncology & carcinogenesis, Febuxostat, business, medicine.drug, rasburicase
وصف الملف: STAMPA
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa0d766d4d900f64c461ab6648d05a09Test
http://hdl.handle.net/11585/722671Test -
6
المؤلفون: Michelle Hui, Azza Hussein
المصدر: Rheumatology. 57
مصطلحات موضوعية: medicine.medical_specialty, Rheumatology, business.industry, medicine, Rasburicase, Pharmacology (medical), Methemoglobinemia, medicine.disease, business, Dermatology, Gout, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9c0f08b947e8dccb8eb3a7f92336eb1bTest
https://doi.org/10.1093/rheumatology/key075.319Test -
7تقرير
المؤلفون: BDD Pharma Ltd
المصدر: A Phase 1, Single Centre, Two-Part, Open Label, Crossover Study in Healthy Volunteers Using Scintigraphy to Characterize the In Vivo Performance of ALLN-346 Enteric Coated Tablets
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05168683Test
-
8تقرير
المصدر: A Randomized, Double-Blind, Placebo-Controlled Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects With Gout and Mild to Moderate Chronic Kidney Disease
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04987294Test
-
9تقرير
المصدر: An Inpatient, Placebo-Controlled Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04987242Test
-
10تقرير
المصدر: A Phase I Randomized, Double-Blind, Placebo Controlled, Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase)
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04829435Test